Pluristem Reports Preliminary Data from its COVID-19 Compassionate Use Program, Treating Seven Patients withAcute Respiratory Failure. All treated patients were in Intensive Care Units...

Pluristem Therapeutics Inc. a leading developer of placenta-based cell therapy products, has signed a Memorandum of Understanding (MOU) for a collaboration withFukushima Medical University,...